We are committed to the cause of brain health in China , and our R&D focuses on various neurological diseases. Our star products in this area include Yangxue Qingnao (granules/pills), Wenfei (Dexzopiclone Tablets), Shaoma Zhijing Keli, and XingnaoJing (intravenous injection), which integrate oral and injectable TCMs and Western medicine.

Our products are used to treat chronic cerebral insufficiency, migraine, tension-type headache, hypertensive headache, and other common neurological diseases. Some products are used in the treatment and prognosis of life-threatening diseases such as stroke and cerebral infarction. In addition, we are strengthening R&D efforts to focus on sleep disorders, transient tic disorder, and other related diseases. Our products, Wenfei and Shaoma Zhijing granules, have filled the existing void in the market for such products. Soon, we will step up R&D of drugs and devices to focus on more segments such as vascular cognitive impairment, Alzheimer's disease, and other related diseases to eventually offer a full range of products and services for early detection, prevention, diagnosis, and treatment of neurological diseases.